PMID: 11613500Jan 1, 1994Paper

The development of modern Japanese pharmaceutical industry (Part 4). From 1906 to 1920, coinciding with the era between the institution and issue of Japanese Pharmacopoeia Third Edition with Fourth Edition (JP III-JP IV)

Yakushigaku zasshi. The Journal of Japanese history of pharmacy
H Yamada

Abstract

The publishing of the Third Edition of Japanese Pharmacopoeia was performed after Russo-Japanese War, on July 2, 1906. In those times, the military and economical power of Japan advanced toward East Asia, and thus gradually, Japan had become one of the powerful force in the world, partly because due to the unexpected victory in the War. Thereafter, in the second decade of the twentieth century, Japan was involved in the World War I, from July, 1914 to November, 1918, which ceased the fire by the defeat of Germanic Allied Countries. In Japan, the next revise of the pharmacopoeia was performed and the Fourth Edition of it was published on December 15, 1920. The Japanese pharmaceutical industry developed remarkably in those times, during the big war and confusion in the market, by accompanying with the suitable and tentative pharmaceutical legislations by the government and the supportive aids to the civilian enterprises in the productions, supplies and distributions of the materials and medicinal products.

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.